The Division of Hematology
at the University of Colorado Denver
The Division of Hematology consists of five full-time faculty members at University of Colorado Hospital and one at the Denver Veterans' Administration Hospital. A close and collegial relationship exists with the Division of Medical Oncology, which makes it possible to sponsor a joint fellowship program and a joint attending program for the hematology-oncology service on 8-East at University of Colorado Hospital.
Financial support for clinical and basic research is provided by standard NIH grants, Small Business Innovative Research grants and patent royalties. Dr. Kolhouse's laboratory has utilized gas chromatography/mass spectrometry to develop new methods for analyzing and quantitating various forms of folic acid as well as new diagnostic tests for establishing and differentiating between pancreatic disease and intestinal disease. Dr. Seligman has established the importance of iron transport and utilization by malignant cells as well as the utility of measuring soluble plasma transferrin receptor levels in the diagnosis of iron deficiency. Drs. Stabler and Allen have worked together in establishing new methods for the diagnosis of vitamin B12 and folate deficiency and have contributed to the growing awareness of the importance of homocysteine as an independent risk factor for vascular disease. Dr. Hassell is interested in the pathogenesis of sickle cell crisis and the recognition of new clinical entities in the fields of coagulation and endothelial cell function. Dr. Calverley has a major interest in the field of platelet and bleeding disorders.
Faculty members attend on the joint hematology-oncology services at University of Colorado Hospital and the Veteran's Administration Hospital. They attend hematology and oncology clinics at the Anschutz Cancer Pavilion and the one hematology clinic that is held at the Veteran's Administration Hospital. Dr. Hassell provides continuity care for patients with sickle cell anemia in both the inpatient and outpatient setting, and Dr. Stabler provides similar service for patients with hemophilia. Dr. Hassell is also the physician in charge of the special anti-coagulation clinic.
Educational activities include teaching the hematology section of the sophomore
pathophysiology course, interactions with medical students during hematology-oncology
electives in the third and fourth years, and interactions with housestaff and
clinical fellows in both the inpatient and outpatient setting. Dr. Kolhouse
is Director of the Clinical Cancer Center.
